scholarly article | Q13442814 |
P356 | DOI | 10.1038/JCBFM.2014.105 |
P8608 | Fatcat ID | release_kbhmdclgmjh6vhycccafiglojq |
P932 | PMC publication ID | 4158661 |
P698 | PubMed publication ID | 24917042 |
P5875 | ResearchGate publication ID | 263014867 |
P50 | author | Kevin K W Wang | Q37837051 |
P2093 | author name string | Claudia S Robertson | |
Fan Lin | |||
Zhihui Yang | |||
P2860 | cites work | The cysteine protease cathepsin B is a key drug target and cysteine protease inhibitors are potential therapeutics for traumatic brain injury | Q24601910 |
Structural insights into TDP-43 in nucleic-acid binding and domain interactions | Q24647225 | ||
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q28131672 | ||
The pathobiology of blast injuries and blast-induced neurotrauma as identified using a new experimental model of injury in mice | Q33448563 | ||
A Drosophila model for TDP-43 proteinopathy | Q33733651 | ||
The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism | Q33786698 | ||
Calpain and caspase: can you tell the difference? | Q33815206 | ||
Comparison of assessment of pigeon sperm viability by contrast-phase microscope (eosin-nigrosin staining) and flow cytometry (SYBR-14/propidium iodide (PI) staining) [evaluation of pigeon sperm viability]. | Q34067776 | ||
TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. | Q34131994 | ||
Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice | Q34519947 | ||
TDP-43 in aging and Alzheimer's disease - a review | Q34566756 | ||
Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles | Q34869120 | ||
Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions | Q34937742 | ||
Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration | Q35773678 | ||
Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q36734898 | ||
TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration | Q36766654 | ||
Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies | Q36955963 | ||
Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity | Q37164410 | ||
TDP-43: a novel neurodegenerative proteinopathy | Q37183193 | ||
TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity | Q37339064 | ||
Calpain as a therapeutic target in traumatic brain injury | Q37686765 | ||
Acute and chronically increased immunoreactivity to phosphorylation-independent but not pathological TDP-43 after a single traumatic brain injury in humans | Q37691547 | ||
Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin | Q39838808 | ||
Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. | Q39839659 | ||
Prion-like disorders: blurring the divide between transmissibility and infectivity | Q39863503 | ||
Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease | Q39960293 | ||
Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. | Q40075711 | ||
Caspase-cleaved TAR DNA-binding protein-43 in Pick's disease | Q40098657 | ||
Calpain as a novel target for treating acute neurodegenerative disorders | Q40369892 | ||
Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways | Q43273248 | ||
Traumatic axonal injury results in biphasic calpain activation and retrograde transport impairment in mice | Q44261064 | ||
Biomarkers in the clinical diagnosis and management of traumatic brain injury | Q45061432 | ||
Alzheimer CSF biomarkers in routine clinical setting | Q45205291 | ||
Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease | Q45291590 | ||
Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology | Q47861971 | ||
Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury | Q48233639 | ||
A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology | Q48249180 | ||
Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study | Q48308861 | ||
The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia. | Q51027167 | ||
Systems biomarkers as acute diagnostics and chronic monitoring tools for traumatic brain injury | Q58114628 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | proteolysis | Q33123 |
traumatic brain injury | Q1995526 | ||
neurotoxicity | Q3338704 | ||
P304 | page(s) | 1444-1452 | |
P577 | publication date | 2014-06-11 | |
P1433 | published in | Journal of Cerebral Blood Flow & Metabolism | Q14663525 |
P1476 | title | Dual vulnerability of TDP-43 to calpain and caspase-3 proteolysis after neurotoxic conditions and traumatic brain injury | |
P478 | volume | 34 |
Q96690858 | 3,6'-Dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation |
Q30361334 | Acute death of astrocytes in blast-exposed rat organotypic hippocampal slice cultures |
Q91670748 | Ammonia induces calpain-dependent cleavage of CRMP-2 during neurite degeneration in primary cultured neurons |
Q47862152 | An update on diagnostic and prognostic biomarkers for traumatic brain injury. |
Q91705054 | Biological links between traumatic brain injury and Parkinson's disease |
Q104134973 | Chronic traumatic encephalopathy-a blueprint for the bridge between neurological and psychiatric disorders |
Q37662585 | Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS In vitro. |
Q38784171 | Degradomics in Neurotrauma: Profiling Traumatic Brain Injury |
Q64069747 | Effect of poly-arginine R18 on neurocyte cell growth via autophagy in traumatic brain injury |
Q42409526 | Examining the Neural and Astroglial Protective Effects of Cellular Prion Protein Expression and Cell Death Protease Inhibition in Mouse Cerebrocortical Mixed Cultures |
Q41480053 | Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats. |
Q37061236 | Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study |
Q91955777 | Prospective clinical biomarkers of caspase-mediated apoptosis associated with neuronal and neurovascular damage following stroke and other severe brain injuries: Implications for chronic neurodegeneration |
Q45327759 | Repetitive blast exposure in mice and combat veterans causes persistent cerebellar dysfunction. |
Q58726656 | Subarachnoid hemorrhage enhances the expression of TDP-43 in the brain of experimental rats and human subjects |
Q35234677 | TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies |
Q92113086 | TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response |
Q33740999 | TDP-43 suppresses tau expression via promoting its mRNA instability |
Q35709639 | Temporal MRI characterization, neurobiochemical and neurobehavioral changes in a mouse repetitive concussive head injury model |
Q64054884 | The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD |
Q91971334 | The Role of TDP-43 in Military-Relevant TBI and Chronic Neurodegeneration |
Q41873070 | The functional and structural changes in the basilar artery due to overpressure blast injury. |
Q47693846 | The roles of intrinsic disorder-based liquid-liquid phase transitions in the "Dr. Jekyll-Mr. Hyde" behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration |
Q47951993 | Traumatic Brain Injury Results in Cellular, Structural and Functional Changes Resembling Motor Neuron Disease. |
Q36373142 | Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant |
Q55710510 | What triggers tauopathy in chronic traumatic encephalopathy? |
Search more.